JW Group is implementing an active open innovation strategy to maximize R&D capabilities. In order to boost the potential of two core platform technologies developed by themselves, they are mobilizing all resources that can be utilized from domestic bio ventures to overseas investment institutions. According to industries on the 13th, JW Group signed a business agreement with ARCH Venture Partners, a U.S. venture capital (VC).

ARCH Venture Partners is the largest venture capital in the United States that invests in companies with early innovative technologies in the healthcare field. It is recognized for commercializing technologies developed by academic institutions, corporate research institutes, and